Structural basis for caveolae assembly and function
小窝组装和功能的结构基础
基本信息
- 批准号:9925038
- 负责人:
- 金额:$ 52.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAddressArchitectureAsthmaBindingBiochemicalBiogenesisBiological AssayBiologyBlood VesselsCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCaveolaeCell membraneCell physiologyCellsChronicComplexComputer SimulationCryoelectron MicroscopyDataDefectDimensionsDiseaseElectron MicroscopyEnsureFluorescence PolarizationFluorescence SpectroscopyGoalsHandHomeostasisInflammatoryKnowledgeLinkLipidsLiteratureLungLung diseasesMalignant neoplasm of lungMapsMembraneMembrane ProteinsModelingMutationProtein RegionProteinsPulmonary FibrosisResearch PersonnelResolutionShapesSignal TransductionStructureSurfaceSystemTestingVariantcaveolin 1cell typeflasksinsightmonomerpersonalized medicinepulmonary arterial hypertensionpulmonary functionsingle moleculestoichiometrythree dimensional structuretrafficking
项目摘要
Flask-shaped invaginations of the plasma membrane known as caveolae are important regulators of the
cardiovascular and pulmonary systems. The membrane protein caveolin-1 (Cav1) is a major structural
component of caveolae and is required for their formation in non-muscle cells. Cav1 is highly expressed in the
lung, and has been linked to lung cancer, asthma, pulmonary fibrosis, pulmonary arterial hypertension, chronic
inflammatory respiratory diseases, and acute lung injury. Cav1 is also known to regulate vascular homeostasis
and was recently identified as one of 15 key drivers of cardiovascular disease. However, the exact
mechanisms by which caveolae form and function normally, and how defects in caveolae give rise to disease
remain incompletely understood.
One of the greatest impediments to our understanding of how caveolae assemble and function is our limited
knowledge about how Cav1 is packed within caveolae. The goal of this proposal is to address this major gap
in knowledge by defining the atomic-level structure of Cav1 oligomers that are known to serve as the
fundamental building blocks of caveolae. To do so, we will utilize a combination of biochemical and
spectroscopic approaches, single molecule electron microscopy, cell biological assays, and computational
modeling to study purified Cav1 oligomeric complexes. One specific aim is to define the overall architecture of
Cav1 oligomers and identify key determinants of their structure and stoichiometry. Another aim is to map the
three-dimensional organization of Cav1 within these oligomers and define structural changes in the protein
associated with the monomer to oligomer transition. The results of these studies will enable us to answer a
number of long-standing questions in the field, including how Cav1 monomers oligomerize to form complexes,
what structural features of Cav1 are required for the protein to bend membranes, how Cav1 complexes interact
amongst themselves to build caveolae, and what regions of Cav1 are available to bind other proteins and
lipids. These insights will be key to furthering our understanding of how Cav1 and caveolae regulate cellular
functions that are critical to ensure proper function of the cardiovascular and pulmonary systems. Finally, our
studies will also have important implications for personalized medicine by providing a structural framework for
understanding how both common variants and disease-associated mutations of Cav1 impact the structure and
function of caveolae.
!
被称为小窝的质膜的烧瓶状内陷是细胞膜的重要调节因子。
心血管和肺系统。膜蛋白Caveolin-1(Cav 1)是一种主要的结构蛋白,
细胞膜是细胞膜小窝的组成部分,是它们在非肌肉细胞中形成所必需的。Cav 1在人的大脑中高度表达,
肺,并已与肺癌,哮喘,肺纤维化,肺动脉高压,慢性
炎性呼吸道疾病和急性肺损伤。已知Cav 1还调节血管稳态
最近被确定为心血管疾病的15个关键驱动因素之一。但具体
小窝形成和功能正常的机制,以及小窝缺陷如何引起疾病
仍然不完全理解。
我们理解小窝如何组装和发挥功能的最大障碍之一是我们有限的
了解Cav 1是如何在小窝中包装的。该提案的目标是解决这一重大差距
通过定义已知作为分子的Cav 1低聚物的原子级结构,
是构成洞穴的基础为此,我们将利用生物化学和
光谱方法,单分子电子显微镜,细胞生物学测定,和计算
建模以研究纯化的Cav 1寡聚复合物。一个具体的目标是定义
Cav 1寡聚体,并确定其结构和化学计量的关键决定因素。另一个目标是绘制
Cav 1在这些寡聚体中的三维组织,并定义蛋白质中的结构变化
与单体到低聚物的转变有关。这些研究的结果将使我们能够回答一个
该领域的一些长期存在的问题,包括Cav 1单体如何寡聚形成复合物,
Cav 1的什么结构特征是蛋白质弯曲膜所必需的,Cav 1复合物如何相互作用
以及Cav 1的哪些区域可用于结合其他蛋白质,
脂质。这些见解将是进一步了解Cav 1和caveolae如何调节细胞的关键。
这些功能对于确保心血管和肺系统的正常功能至关重要。最后我们
研究还将通过提供以下结构框架,对个性化医疗产生重要影响:
了解Cav 1的常见变异和疾病相关突变如何影响结构,
小窝的功能。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne K Kenworthy其他文献
Anne K Kenworthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne K Kenworthy', 18)}}的其他基金
Structure and Function of Non-Conventional Caveolins
非常规小窝蛋白的结构和功能
- 批准号:
10638902 - 财政年份:2023
- 资助金额:
$ 52.77万 - 项目类别:
Small Molecule Tools for Modulating Membrane Rafts
用于调节膜筏的小分子工具
- 批准号:
10474445 - 财政年份:2020
- 资助金额:
$ 52.77万 - 项目类别:
Small Molecule Tools for Modulating Membrane Rafts
用于调节膜筏的小分子工具
- 批准号:
10250522 - 财政年份:2020
- 资助金额:
$ 52.77万 - 项目类别:
Small Molecule Tools for Modulating Membrane Rafts
用于调节膜筏的小分子工具
- 批准号:
10029455 - 财政年份:2020
- 资助金额:
$ 52.77万 - 项目类别:
Roles of Cholesterol and Membrane Nanodomains in the Amyloidogenic Pathway
胆固醇和膜纳米结构域在淀粉样蛋白生成途径中的作用
- 批准号:
9333750 - 财政年份:2017
- 资助金额:
$ 52.77万 - 项目类别:
Function and assembly of toxin-stabilized domains
毒素稳定结构域的功能和组装
- 批准号:
8532431 - 财政年份:2013
- 资助金额:
$ 52.77万 - 项目类别:
Function and assembly of toxin-stabilized domains
毒素稳定结构域的功能和组装
- 批准号:
8843013 - 财政年份:2013
- 资助金额:
$ 52.77万 - 项目类别:
Function and assembly of toxin-stabilized domains
毒素稳定结构域的功能和组装
- 批准号:
9925238 - 财政年份:2013
- 资助金额:
$ 52.77万 - 项目类别:
Function and assembly of toxin-stabilized domains
毒素稳定结构域的功能和组装
- 批准号:
9403684 - 财政年份:2013
- 资助金额:
$ 52.77万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 52.77万 - 项目类别:
Research Grant